IP Library › Assignment 043844/0275
Patent Assignment
Reel/Frame 043844/0275

Assignment of Assignor's Interest

Recorded: 2017-10-12 Pages: 3
Assignor
KARO PHARMA AB
Executed: 2017-09-07
Assignee
OASMIA PHARMACEUTICAL AB
VALLONGATAN 1, UPPSALA, 752 28, SWEDEN
Covered Properties (2)
Novel Estrogen Receptor Ligands
Patent: 8,367,665 →
Application: 12/736,438 →
Publication: US 2011/0190294
Novel Estrogen Receptor Ligands
Patent: 8,653,072 →
Application: 13/739,124 →
Publication: US 2013/0131061
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 2, 2010
From: RHONNSTAD, PATRIK; KALLIN, ELISABET; APELQVIST, THERESA; WENNERSTAL, MATTIAS
To: KARO BIO AB
Reel/Frame 025237/0605 →
Change of Name Jun 27, 2017
From: KARO BIO AB
To: KARO PHARMA AB
Reel/Frame 043008/0358 →
Assignment of Assignor's Interest Sep 11, 2019
From: ARDENIA INVESTMENTS, LTD.
To: OASMIA PHARMACEUTICAL AB
Reel/Frame 050338/0853 →